Publications News Subscribe Submit Article About Us Privacy Policy | Contact

In this issue: Science News  | Current Publications | Industry News  | Policy News | Events
 Subscribe |  Unsubscribe


TOP STORIES

One Factor is Sufficient - Even in Human Cells
After successful experiments with murine cells, German researchers have now reprogrammed human somatic cells with a single factor. [Max Planck Institute for Molecular Biomedicine, Munster]

mFreSR_645x110_v01


SCIENCE NEWS

Complimentary Webinar: Feeder-independent growth of hESCs & hiPSCs using mTeSR(R)1

Modeling Diabetes with Stem Cells
A technique that allows the insulin-producing cells that are destroyed by type 1 diabetes to be re-created in the lab could help researchers understand how the disease develops and perhaps lead to more effective treatments for the condition. [Harvard University, Boston]

Stemedica Achieves Major Milestone - Company Receives License to Manufacture Clinical Grade Stem Cells
Stemedica Cell Technologies, Inc. announced recently that it has been granted a license by the State of California's Food & Drug Branch to manufacture stem cells for human clinical trials. [Stemedica Cell Technologies, Inc., San Diego]

New Stem Cell Treatment 'Being Used by Patients to Avoid Hip Replacements'
Doctors in Southampton are using the pioneering technique, where a patient's damaged bones are repaired using their own purified cells from bone marrow extracted from the pelvis. [University of Southampton, Southampton]

Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.

Aldefluor_645x110_v01


CURRENT PUBLICATIONS

Definitive Proof for Direct Reprogramming of Hematopoietic Cells to Pluripotency
This paper shows definitive proof of direct reprogramming of murine hematopoietic cells with no rearranged genes. [Blood]

Stem Cell Modulators: a Small Molecule and Biologic Approach to Stem Cell Therapeutics
The quickest way to bring in the horizon for stem cell medicines might be through the use of conventional pharmaceuticals to modulate key stem cell pathways. [Drug Discovery Today: Therapeutic Strategies]

Mesenchymal to Embryonic Incomplete Transition of Human Cells by Chimeric OCT4/3 (POU5F1) with Physiological Co-activator EWS
To investigate whether cells of mesenchymal origin acquire embryonic phenotypes, the researchers generated human cells of mesodermal origin with overexpression of the chimeric OCT4/3 gene with physiological co-activator EWS, which is driven by the potent EWS promoter by translocation. [Experimental Cell Research]

StemsoftLeader_ESCNCN_SS


INDUSTRY NEWS

Connexon Creative Launches Cord Blood News
Cord Blood News is a weekly e-newsletter that keeps members of the cord blood community informed by providing the latest news from all areas of the field, including its science, research, policy, and business.

STEMCELL Technologies Inc. to Host Stem Cell Training Courses
STEMCELL Technologies has announced the schedule for their fall training program including mesenchymal, mammary, neural, hematopoietic, human embryonic and induced pluripotent stem cell biology.

Geron Comments on FDA Hold on Spinal Cord Injury Trial
Geron Corporation recently provided additional comments on the recent clinical hold on its Spinal Cord Injury Investigational New Drug. [Geron, Menlo Park]

BrainStorm Cell Therapeutics Enters into Agreement for Clinical-Grade Stem Cell Production for ALS
BrainStorm Cell Therapeutics Inc. announced recently that it has entered into an agreement with Protein Production Services Ltd. to start Good Manufacturing Practice production of its stem cell therapeutic product. [BrainStorm Cell Therapeutics, Petach Tikvah]

Stem Cell Firm Plans Russia's 1st Post-crisis Initial Public Offering
Russia's Stem Cell Institute is seeking to attract some 150 million rubles ($4.75 million) from investors in what would be the country's first initial public offering in more than a year. [The Stem Cell Institute, Moscow]

Drug, Biotech Research Spending Hangs Tough
Corporate America's research spending shrank 4% overall, or $1.9 billion, from the fourth quarter of 2007 through the second quarter of this year, according to data compiled by Capital IQ on 961 U.S. companies. But many health-care companies have boosted their research outlays.

Indicted Scientist Still Confident of Cloning Authentic Stem Cells
Disgraced cloning scientist Hwang Woo-suk seems to have returned to his old ways.


POLICY NEWS

New York Commits $20.4M to Stem Cell Research
Governor David Paterson said $5.4 million would earmarked to recruit research fellows and transition them into research institutions in New York.


EVENTS

World Stem Cell Summit 2009
September 23-25, 2009
Baltimore, United States

TERMIS 2nd World Congress 2009
August 31 - September 3, 2009
Seoul, South Korea

The 2nd Annual Maryland Stem Cell Research Symposium
September 21 2009
Baltimore, United States

49th American Society for Cell Biology Annual Meeting
December 5-9, 2009
San Diego, United States

Stem Cells and Regenerative Medicine World Congress
January 20-21, 2010
San Francisco, United States

Molecular Medicine Tri-Conference 2010
February 3-5, 2010
San Francisco, United States

ISSCR 8th Annual Meeting
June 16-19, 2010
San Francisco, United States

 Learn more about Embryonic Stem Cell News:  Archives | Events  | Subscribe | Contact Us
This email was sent by: Connexon Creative
400-570 W. 7th Avenue Vancouver, British Columbia V5Z 1B3 Canada